Arcturus Therapeutics Holdings (ARCT) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Arcturus Therapeutics Holdings (ARCT) over the last 5 years, with Q3 2025 value amounting to -$0.49.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) fell 8846.15% to -$0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.46, marking a year-over-year decrease of 512.82%. This contributed to the annual value of -$3.0 for FY2024, which is 16854.77% down from last year.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) amounted to -$0.49 in Q3 2025, which was down 8846.15% from -$0.34 recorded in Q2 2025.
- Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted)'s 5-year high stood at $4.44 during Q4 2022, with a 5-year trough of -$2.07 in Q2 2021.
- Over the past 5 years, Arcturus Therapeutics Holdings' median EPS (Weighted Average and Diluted) value was -$0.73 (recorded in 2022), while the average stood at -$0.6.
- Per our database at Business Quant, Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) skyrocketed by 40204.08% in 2022 and then crashed by 15347.59% in 2024.
- Quarter analysis of 5 years shows Arcturus Therapeutics Holdings' EPS (Weighted Average and Diluted) stood at -$1.47 in 2021, then skyrocketed by 402.04% to $4.44 in 2022, then crashed by 109.88% to -$0.44 in 2023, then plummeted by 153.35% to -$1.11 in 2024, then soared by 55.91% to -$0.49 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.49 for Q3 2025, versus -$0.34 for Q2 2025 and -$0.52 for Q1 2025.